Literature DB >> 31309273

[Current importance of heavy fluids as intraoperative aids in vitreoretinal surgery].

Nicolas Feltgen1, Hans Hoerauf2.   

Abstract

A major milestone in the treatment of complex retinal detachment was the development of heavy fluids as intraoperative short-term tamponades. Since the introduction liquid perfluorocarbons and hydrofluorocarbons are particularly noteworthy. Irrespective of the suitability of the substances in principle, the purity during the manufacturing process is a decisive factor that determines possible side effects. Also, the direct exchange with silicone oil can lead to mixing with disadvantageous results. Retinal surgeons should be informed about the properties of the tamponades used. Despite all expectations, the heavy liquids could not become established compared to silicone oil as a long-term tamponade, which is why their domain is the short-term intraoperative use.

Entities:  

Keywords:  Hydrofluorocarbons; Perfluorocarbons; Retinal detachment; Vitrectomy; Vitreoretinal surgery

Mesh:

Substances:

Year:  2019        PMID: 31309273     DOI: 10.1007/s00347-019-0935-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  37 in total

Review 1.  New substances for intraocular tamponades: perfluorocarbon liquids, hydrofluorocarbon liquids and hydrofluorocarbon-oligomers in vitreoretinal surgery.

Authors:  K Kobuch; I H Menz; H Hoerauf; J H Dresp; V P Gabel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-09       Impact factor: 3.117

2.  Intraoperative perfluorocarbon liquids in the management of proliferative vitreoretinopathy.

Authors:  S Chang; E Ozmert; N J Zimmerman
Journal:  Am J Ophthalmol       Date:  1988-12-15       Impact factor: 5.258

3.  A new way of removing silicone oil from the surface of silicone intraocular lenses.

Authors:  S Langefeld; B Kirchhof; H Meinert; T Roy; A Aretz; N F Schrage
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1999-03       Impact factor: 3.117

4.  Perfluorohexylethan (O62) as ocular endotamponade in complex vitreoretinal surgery.

Authors:  Hans Hoerauf; Johann Roider; Karin Kobuch; Horst Laqua
Journal:  Retina       Date:  2005-06       Impact factor: 4.256

5.  Combined use of partially fluorinated alkanes, perfluorocarbon liquids and silicone oil: an experimental study.

Authors:  H Hoerauf; K Kobuch; J Dresp; D H Menz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-06       Impact factor: 3.117

6.  Factors contributing to the emulsification of intraocular silicone and fluorosilicone oils.

Authors:  K Nakamura; M F Refojo; D V Crabtree
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-04       Impact factor: 4.799

7.  Determination of the solubility of perfluorocarbon liquids in silicone oil in vitro and in vivo.

Authors:  Hans Hoerauf; Frank Faude; Dirk-Henning Menz; Joachim Dresp; Peter Wiedemann; Horst Laqua
Journal:  Retina       Date:  2002-04       Impact factor: 4.256

8.  One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration.

Authors:  A Abdel-Meguid; A Lappas; K Hartmann; F Auer; N Schrage; G Thumann; B Kirchhof
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

9.  Low viscosity liquid fluorochemicals in vitreous surgery.

Authors:  S Chang
Journal:  Am J Ophthalmol       Date:  1987-01-15       Impact factor: 5.258

10.  How to Ward Off Retinal Toxicity of Perfluorooctane and Other Perfluorocarbon Liquids?

Authors:  Dirk-Henning Menz; Nicolas Feltgen; Helge Menz; Bernd-Kristof Müller; Thorsten Lechner; Joachim Dresp; Hans Hoerauf
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-10-01       Impact factor: 4.799

View more
  1 in total

1.  New technique for removal of perfluorocarbon liquid related sticky silicone oil and literature review.

Authors:  Hai-Shuang Lin; Yong-Ping Tang; Lu Zhang; En-Ze Liu; Ling-Ying Ye; Ming-Na Xu; Rong-Han Wu; Zhi-Xiang Hu
Journal:  Int J Ophthalmol       Date:  2021-12-18       Impact factor: 1.779

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.